Form 4: Heartflow Director Buys 40,000 Shares
Insider Transaction Report
Heartflow Director Jeffrey C Lightcap purchased 40,000 shares of common stock at a weighted average price of $26.342, signaling increased insider confidence.
Summary
- Director Jeffrey C Lightcap acquired 40,000 shares of Heartflow, Inc. common stock.
- The transaction occurred on December 16, 2025, and was made pursuant to a Rule 10b5-1 trading plan.
- The shares were purchased at a weighted average price of $26.342 per share, with individual trade prices ranging from $25.645 to $26.750.
- Following this transaction, Mr. Lightcap directly owns 40,000 shares of Heartflow common stock.
- Mr. Lightcap also has indirect beneficial ownership of 4,615,542 shares through HCPCIV 1, LLC, 833,075 shares through HealthCor Partners Fund II, L.P., and 1,248,939 shares through HealthCor Partners Fund, L.P., for which he is a controlling member.
Sentiment
Score: 8
Explanation: The significant purchase of a large block of shares by a director indicates strong insider confidence in the company's current valuation and future prospects, which is a highly positive signal for investors.
Positives
- A director, Jeffrey C Lightcap, purchased a significant block of 40,000 shares of common stock, indicating strong insider confidence in the company's future prospects.
- The purchase was made at a weighted average price of $26.342 per share, representing a substantial personal investment.
Risks
- Mr. Lightcap disclaims beneficial ownership of the shares held by HCPCIV 1, LLC, HealthCor Partners Fund II, L.P., and HealthCor Partners Fund, L.P., except to the extent of his pecuniary interest therein, which could imply limited direct financial exposure or control over those specific shares.
Future Outlook
N/A
Industry Context
N/A
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Disclosure | The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase of equity securities. | 12/16/2025 | Indicates a pre-arranged trading strategy designed to comply with insider trading laws, potentially reducing concerns about opportunistic trading and enhancing transparency. |
Related Party Transactions
- Jeffrey C Lightcap is a controlling member of HCPCIV 1, LLC, HealthCor Partners Fund II, L.P., and HealthCor Partners Fund, L.P., which collectively hold 6,697,516 shares of Heartflow common stock, indicating a significant indirect interest through related entities.
Stakeholder Impact
- Shareholders: Insider buying by a director can be interpreted as a strong positive signal, potentially increasing investor confidence and demand for the stock, which may lead to upward price movement.
Key Dates
| Date | Description |
|---|---|
| 12/16/2025 | Date of earliest transaction (purchase of common stock by Director Jeffrey C Lightcap) |
| 12/17/2025 | Date of Form 4 filing with the SEC |
Recommendation
buyThe significant purchase of common stock by a director, especially under a Rule 10b5-1 plan, suggests strong conviction in the company's intrinsic value and future growth trajectory. This insider buying activity often precedes positive company developments or reflects a belief that the stock is undervalued, making it a compelling 'buy' signal for seasoned investors.
Keywords
Heartflow, HTFL, insider trading, director purchase, stock acquisition, Form 4, beneficial ownership, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.